|
| Monday, October 31, 2016 |
|
|
雅各臣完成收購香港一家具信譽的非專利藥製造商 |
| 從事非專利藥及中成藥研發、生產、市場推廣及銷售的領先企業，以及香港最大的非專利藥公司—雅各臣科研製藥有限公司（「雅各臣」或「集團」；股份代號：2633）今天宣佈完成收購Cawah Holdings Limited（「Cawah Holdings」）及其附屬公司美達藥廠有限公司（「美達藥廠」），彼為香港一家具信譽的非專利藥製造商，總代價為100,000,000港元。 more info >> |
|
|
Jacobson Pharma Completes Acquisition of Reputable Generic Drug Manufacturer in Hong Kong |
| Jacobson Pharma Corporation Limited today announces the completion of the acquisition of Cawah Holdings Limited ("Cawah Holdings") and its subsidiary namely, Medipharma Limited ("Medipharma") which is a reputable generic drug manufacturer in Hong Kong, at a total consideration of HK$100,000,000. more info >> |
|
| Monday, September 12, 2016 |
|
|
雅各臣科研制药有限公司于香港联合交易所主板上市详情 |
| 雅各臣科研制药有限公司（「雅各臣」或「集团」）是从事非专利药及中成药研发、生产、市场推广及销售的领先企业及垂直整合制造商，亦是香港最大的非专利药公司。 more info >> |
|
|
雅各臣科研製藥有限公司於香港聯合交易所主板上市詳情 |
| 雅各臣科研製藥有限公司（「雅各臣」或「集團」）是從事非專利藥及中成藥研發、生產、市場推廣及銷售的領先企業及垂直整合製造商，亦是香港最大的非專利藥公司。 more info >> |
|
|
Jacobson Pharma Corporation Limited Announces Details of the Proposed Listing on the Main Board of SEHK |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"), a leading company engaged in the research, development, production, marketing and sales of and a vertically integrated manufacturer of Generic Drugs ("generics") and Proprietary Chinese Medicines ("PCM") and the largest generic drug company in Hong Kong, has commenced the Hong Kong Public Offering on 8 September 2016 (Thursday), and will end at 12:00 noon on 13 September 2016 (Tuesday). more info >> |
|
| Wednesday, September 7, 2016 |
|
|
雅各臣科研制药有限公司公布计划于香港联合交易所主板上市详情 |
雅各臣科研制药有限公司（「雅各臣」或「集团」）是从事非专利药及中成药研发、生产、市场推广及销售的领先企业及垂直整合制造商，亦是香港最大的非专利药公司。集团今天公布其股份于香港联合交易所有限公司（「联交所」）主板上市建议的详情。
more info >> |
|
|
雅各臣科研製藥有限公司公佈計劃於香港聯合交易所主板上市詳情 |
雅各臣科研製藥有限公司（「雅各臣」或「集團」）是從事非專利藥及中成藥研發、生產、市場推廣及銷售的領先企業及垂直整合製造商，亦是香港最大的非專利藥公司。集團今天公佈其股份於香港聯合交易所有限公司（「聯交所」）主板上市建議的詳情。
more info >> |
|
|
Jacobson Pharma Corporation Limited Announces Details of the Proposed Listing on the Main Board of SEHK |
| Jacobson Pharma Corp Ltd, a vertically integrated manufacturer of Generic Drugs and Proprietary Chinese Medicines ("PCM") and the largest generic drug company in Hong Kong, today announced the details for the proposed listing of its shares on the Main Board of the Stock Exchange of Hong Kong Limited ("SEHK"). more info >> |
|
|
|
|
